- BOARD CHANGE
- Arecor and TRx Biosciences research collaboration
- Arecor announces launch of Ogluo® in Netherlands
- Year End Trading Update
- Arecor announces update on INBRX-101
- Arecor granted key European patent
- Expansion of specialty hospital collaboration
- Appointment of SVP for Tetris Pharma Ltd
- Agreement with global medical products company
- Arecor Continues Collaboration with Lilly
More ▼
Key statistics
As of last trade Arecor Therapeutics PLC (AREC:LSE) traded at 133.00, 6.40% above its 52-week low of 125.00, set on Apr 17, 2024.
52-week range
Open | 136.50 |
---|---|
High | 135.00 |
Low | 135.00 |
Bid | 133.00 |
Offer | 140.00 |
Previous close | 136.50 |
Average volume | 40.58k |
---|---|
Shares outstanding | 30.63m |
Free float | 14.86m |
P/E (TTM) | -- |
Market cap | 41.81m GBP |
EPS (TTM) | -0.3108 GBP |
Data delayed at least 20 minutes, as of Apr 26 2024 08:16 BST.
More ▼